Indeed, it has been shown that the risk for AD increases from 20% to 47% to 91% in non-carrier (ApoE4 -/-), heterozygous (ApoE4 +/-), and homozygous (ApoE4 +/+) subjects, respectively. The gene discussed is APOE; the disease is Alzheimer disease.